Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cell and Stem Cell(Electronic Edition) ›› 2017, Vol. 07 ›› Issue (05): 271-276. doi: 10.3877/cma.j.issn.2095-1221.2017.05.004

Special Issue:

• Original Research • Previous Articles     Next Articles

Influence of transplantation with basic fibroblast growth factor gene-transfected bone mesenchymal stem cells on heart function in rats with heart failure

Zenghua Lai1,(), Xuekai Dou1, Chunwen Jia1, Chaohui Jiang1   

  1. 1. Department of Cardiology, the 174th Hospital of the PLA, Affiliated Chenggong Hospital of Xiamen University, Xiamen 360001, China
  • Received:2017-05-19 Online:2017-10-01 Published:2017-10-01
  • Contact: Zenghua Lai
  • About author:
    Corresponding author: Lai Zenghua, Email:

Abstract:

Objective

To explore the influence of transplantation with basic fibroblast growth factor (bFGF) gene-transfected bone mesenchymal stem cells (BMSCs) on heart function in rats with heart failure.

Methods

A heart failure model of SD rats was induced by intraperitoneal injection with adriamycin. The 33 survived rats were randomly divided into 3 groups: a model group, a BMSCs group and a BMSCs+bFGF group (n= 11 for all). Another 8 rats served as control. BMSCs at the third passage were transfected with bFGF and labeled with BrdU. BMSCs (3×106), bFGF-transfected BMSCs (3×106), or culture medium were respectively transplanted into rats via the tail vein. Cardiac function was evaluated with the use of a physiological recorder. The hearts were analyzed by immunohistochemical staining to identify the transplanted BrdU-labeled cells. The expressions of bFGF protein and mRNA in the heart tissues were respectively determined by Western Blotting and real time PCR. One-Way ANOVA or Fisher's exact test was used in the analysis as appropriately.

Results

Four weeks after transplantation, hemodynamic measurements showed LVSP (121.13±12.28) mmHg, LVDEP (3.86±1.25) mmHg, LV +dP/dt (3671.25±172.50) mmHg/s, LV-dP/dt (3221.63±259.57) mmHg/s in the normal control group; LVSP (81.29±12.39) mmHg, LVDEP (16.43±4.12) mmHg, LV+dP/dt (2344.29±98.63) mmHg/s, LV-dP/dt (2244.29±103.10) mmHg/s in the model group; LVSP (97.00±6.39) mmHg, LVDEP (12.00±2.73) mmHg, LV+dP/dt (2876.25±118.31) mmHg/s, LV-dP/dt (2726.25±303.23) mmHg/s in the BMSCs group, and LVSP (109.38±12.78) mmHg, LVDEP (9.25±1.67) mmHg, LV+dP/dt (3037.50±161.22) mmHg/s, LV-dP/dt (3000.13±149.77) mmHg/s in the BMSCs+bFGF group. The parameters were all significantly improved (F= 17.29, 36.61, 111.11 and 26.54 respectively, Pall < 0.01) after the transplantation. BrdU-labeled transplanted BMSCs could be found in the hearts of the recipients. The expression of bFGF mRNA in the heart tissues were significantly increased in the model group (1.28±0.06) than in the control group (t= 10.46, P< 0.01); in the BMSCs group (1.37±0.05) than in the model group (t?= 3.39,P< 0.01); and in the BMSCs+bFGF group (1.44±0.03) than in the BMSCs group (t=2.86,P= 0.01). As shown by Western Blotting test, the bFGF protein expression level of the heart tissues was the lowest in the normal control, but significantly higher in the model group than in the control group (1.31±0.09vs1.00±0.00,t= 5.48,P= 0.01), in the BMSCs group than in the model group (1.46?±0.05vs1.31±0.09,t= 2.68,P= 0.03), and in the BMSCs+bFGF group than in the BMSCs group (1.84±0.09vs1.46±0.05,t= 6.79,P< 0.01).

Conclusion

Transplantation with BMSCs or bFGF-transfected BMSCs can both improve cardiac function in rats with adriamycin-induced heart failure, while the effect of bFGF-transfected BMSCs may be better than BMSCs only.

Key words: Basic fibroblast growth factor, Mesenchymal stem cells, Cell transplantation, Heart failure

京ICP 备07035254号-3
Copyright © Chinese Journal of Cell and Stem Cell(Electronic Edition), All Rights Reserved.
Tel: 0086-591-87982783 E-mail: ccsct@vip.163.com
Powered by Beijing Magtech Co. Ltd